Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Cancer PHGKB

Specific PHGKB|Cancer|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.

spot light Spotlight

Harnessing cancer genomes for precision oncology

From the abstract: "Precision oncology has just received a boost: a report on the prevalence of mutations in cancer driver genes based on whole genome sequencing of 10,000 clinical cases. The challenge ahead lies in how to explore the data to accelerate new discoveries in cancer biology while advancing precision oncology. "

Advancing Genomic Cancer Medicine in Rural and Underserved States

From the article: "In the evolving landscape of oncology, the integration of powerful genomic technologies into practice has ushered in a new era of precision cancer medicine. Complex genomic information such as mutational analyses, transcriptional signatures, and polygenic risk scores have become key diagnostics guiding therapeutic decisions and management of inherited cancer risk. However, the expertise to interpret these data for clinical decision-making remains constrained and is a significant challenge for community oncologists, especially those in rural regions and in medically underserved areas. While physical access to these tests is readily available, poor access to interpretive expertise has become the key limiting factor. "

Benefits for children with suspected cancer from routine whole-genome sequencing

From the abstract: " Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every child with suspected cancer can change patient management. We collected WGS variant calls and clinical and diagnostic information from 281 children (282 tumors) across two English units (n=152 from a hematology center, n?=?130 from a solid tumor center) where WGS had become a routine test. Our key finding was that variants uniquely attributable to WGS changed the management in ~7% (20 out of 282) of cases while providing additional disease-relevant findings, beyond standard-of-care molecular tests, in 108 instances for 83 (29%) cases."

A roadmap for affordable genetic medicines

From the abstract: "Nineteen genetic therapies have been approved by the U.S. Food and Drug Administration (FDA) to date, a number that now includes the first CRISPR genome editing therapy for sickle cell disease, CASGEVY (exagamglogene autotemcel). This extraordinary milestone is widely celebrated because of the promise for future genome editing treatments of previously intractable genetic disorders and cancers. At the same time, such genetic therapies are the most expensive drugs on the market, with list prices exceeding $4 million per patient. "


news Latest News and Publications
Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19. External Web Site Icon
Ha Dat P, et al. Cell & bioscience 2024 0 0. (1) 115
Incidental pulmonary nodules: Natural language processing analysis of radiology reports. External Web Site Icon
Grolleau Emmanuel, et al. Respiratory medicine and research 2024 0 0. 101136
Cuproptosis-associated lncRNA impact prognosis in patients with non-small cell lung cancer co-infected with COVID-19. External Web Site Icon
Li Jing, et al. Journal of cellular and molecular medicine 2024 0 0. (17) e70059
Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis. External Web Site Icon
Otálora-Otálora Beatriz Andrea, et al. Frontiers in cellular and infection microbiology 2024 0 0. 1425388
IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization. External Web Site Icon
Fu Chong, et al. Frontiers in immunology 2024 0 0. 1452849
Advances in Oral Exfoliative Cytology: From Cancer Diagnosis to Systemic Disease Detection. External Web Site Icon
Wang Shan, et al. Diagnostic cytopathology 2024 0 0.
Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection. External Web Site Icon
Yazawa Shunsuke, et al. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024 0 0.
Activated Factor VII-Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer. External Web Site Icon
Moruzzi Sara, et al. Diagnostics (Basel, Switzerland) 2024 0 0. (16)
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases. External Web Site Icon
Huang Yiheng, et al. Biomolecules 2024 0 0. (8)
An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease. External Web Site Icon
Samrat Subodh Kumar, et al. Viruses 2024 0 0. (8)

More

About Cancer PHGKB

Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more

Content Summary

Common Type

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP